U.S., Feb. 14 -- ClinicalTrials.gov registry received information related to the study (NCT06824363) titled 'ProofPrincip IntraTu TCells SinglDoseImmunCheckpoinInhib Gastro-Esophage Adenocarcinoma W/A... Read More
U.S., Feb. 14 -- ClinicalTrials.gov registry received information related to the study (NCT06825520) titled 'Investigating Changes in Premonitory Urges During Habit Reversal Training for Tics' on Feb.... Read More
U.S., Feb. 14 -- ClinicalTrials.gov registry received information related to the study (NCT06825429) titled 'Group Exercise in Cancer Patients Under Active Treatment: Feasibility Pilot Study.' on Jan.... Read More
U.S., Feb. 14 -- ClinicalTrials.gov registry received information related to the study (NCT06824129) titled 'Clinical Performance Evaluation of the QIAstat-Dx(R) cUTI Plus AMR' on Feb. 07. Brief Summ... Read More
U.S., Feb. 14 -- ClinicalTrials.gov registry received information related to the study (NCT06824389) titled 'Evaluate the Performance of Large Language Models in Ophthalmologic Patient Consultation' o... Read More
U.S., Feb. 14 -- ClinicalTrials.gov registry received information related to the study (NCT06824844) titled 'The Effect of 0.05% CsA Eye Drops on Diabetic Patients with Dry Eye Disease' on Feb. 07. B... Read More
U.S., Feb. 14 -- ClinicalTrials.gov registry received information related to the study (NCT06824792) titled 'Optimal Standard Treatment Selection for Solid Tumor Patients by Biologically-informed Mult... Read More
U.S., Feb. 14 -- ClinicalTrials.gov registry received information related to the study (NCT06826144) titled 'Chronic Remote Ischemic Conditioning in Small Infarctions Associated with Stent-assisted Co... Read More
U.S., Feb. 14 -- ClinicalTrials.gov registry received information related to the study (NCT06824662) titled 'Phase 0 With Expansion Phase Clinical Trial of Quisinostat Plus Radiotherapy in Newly-diagn... Read More
U.S., Feb. 14 -- ClinicalTrials.gov registry received information related to the study (NCT06824467) titled 'A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Treatment ... Read More